SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 33.14 |
| Enterprise Value ($M) | 20.12 |
| Book Value ($M) | 0.81 |
| Book Value / Share | 0.02 |
| Price / Book | 40.78 |
| NCAV ($M) | -0.01 |
| NCAV / Share | -0.00 |
| Price / NCAV | -4,635.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -23.54 |
| Return on Assets (ROA) | -2.22 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.01 |
| Current Ratio | 1.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 14.68 |
| Assets | 15.50 |
| Liabilities | 14.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -30.96 |
| Net Income | -29.92 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -33.54 |
| Cash from Investing | 0.00 |
| Cash from Financing | 23.65 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Schonfeld Strategic Advisors LLC | 2.82 | -25.82 | |
| 13G/A | CVI Investments, Inc. | 4.90 | ||
| 13D/A | Vedanta Associates-R, LP | 12.40 | ||
| 13D/A | Bhat Laxminarayan | 6.80 | 10.52 | |
| 13G/A | Armistice Capital, Llc | 9.99 | 90.36 | |
| 13D/A | Saxena Parag | 16.90 | ||
| 13G | Integrated Core Strategies (us) Llc | 5.20 | ||
| 13D/A | Vedanta Partners, Llc | 18.50 | -2.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 92,919 | 319,572 | 29.08 | |
| 85,724 | 267,386 | 32.06 | |
| 136,279 | 364,033 | 37.44 | |
| 294,219 | 917,615 | 32.06 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RNAZ – TransCode Therapeutics, Inc. | RNTX – Rein Therapeutics Inc. |
| RNXT – RenovoRx, Inc. | RZLT – Rezolute, Inc. |
| SABS – SAB Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io